Stock screenerAll disclosures →
EDGAR →
HYPR
Conviction 92HealthcareScan · Thu, Jun 25, 2026HYPR$1.69+15.41%
ResistanceSupportVol 14Insider sell2
Vol MA14 964.73K
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price1.69
Change+15.41%
Gap+1.37%
Rel volume3.75×
Avg volume830.84K
Avg $ vol1.27M
SMA 201.47
SMA 501.50
SMA 2001.27
Price vs 50+12.67%
Price vs 200+32.43%
MA stackbullish
50/200 cross—
Supertrendup · 1.30
RSI (14)63
MACD hist0.02
MACD crossbull · 4d
Stoch %K / %D98 / 55
ADX (14)21
+DI / −DI33 / 13
RSI divergence—
MACD divergenceBullish
ATR %+6.85%
ADR %6.72%
52w high2.20
52w low0.6874
From 52w high-23.41%
Above 52w low+145.13%
New 52w highNo
SqueezeFired
Bollinger width23.52%
%B1.12
Donchian pos98.48%
Donchian high1.69
Donchian low1.36
AVWAP (52w high)1.29
vs AVWAP high+30.55%
AVWAP (52w low)1.30
vs AVWAP low+29.93%
OBV trendUp
Chaikin MF (20)0.03
Today vs 20d3.75×
Avg vol (14d)964.73K
Avg vol (20d)830.84K
Avg $ vol (20d)1.27M
Market cap137.82M
RS 3m (vs SPY)+14.70%
RS 6m (vs SPY)+24.99%
RS line new highNo
Trend template6/8
Technical rank89.5
1 week+21.22%
1 month+1.51%
3 months+44.02%
6 months+56.02%
1 year+132.99%
YTD+73.91%
P/E-3.87
P/B4.01
P/S10.16
P/FCF-4.73
EPS-0.4300
Div yield—
ROE-103.53%
ROA-58.96%
Debt/Eq0.38
Current5.52
EV/EBITDA-3.05
Gross margin49.79%
Net margin-262.29%
Rev growth5.22%
EPS growth12.64%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value110.17M
Revenue3.9M
Net income-8.62M
Gross profit1.98M
Free cash flow-29.13M
IndustryELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
ExchangeNasdaq
Shares out84.22M
Employees102
ListedThu, Dec 23, 2021
Free float69.41M
Float %83.2%
Short interest1.62M
Days to cover2.8d
Short volume61.9%
Squeeze score48 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeA+
Conviction92 / 100
Pattern quality—
Tech rank89.5 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance1.88
Support1.36
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in HYPR
No recent disclosed trades by Congress in HYPR. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in HYPR · 5 buys · 2 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Wolterman Dan Director · Stock Options (right to buy) · 2026-06-03 | Grant | 52.6K | $0 | 2026-06-03 | 2026-06-04 |
HALE BRETT CFO and CAO · Class A Common Stock · 2026-05-26 | Sell | 6.05K | $10K | 2026-05-26 | 2026-05-27 |
TEISSEYRE THOMAS Chief Operating Officer · Class A Common Stock · 2026-05-26 | Sell | 6.05K | $10K | 2026-05-26 | 2026-05-27 |
Wolterman Dan Director · Stock Options (right to buy) · 2026-05-22 | Grant | 157.7K | $0 | 2026-05-22 | 2026-05-22 |
ROTHBERG JONATHAN M Director · Stock Options (right to buy) · 2026-05-22 | Grant | 157.7K | $0 | 2026-05-22 | 2026-05-22 |
Dahldorf John T Director · Stock Options (right to buy) · 2026-05-22 | Grant | 157.7K | $0 | 2026-05-22 | 2026-05-22 |
Fattori Ruth A Director · Stock Options (right to buy) · 2026-05-22 | Grant | 157.7K | $0 | 2026-05-22 | 2026-05-22 |
SEC filings
EDGAR filings in HYPR
No recent SEC filings on file for HYPR.
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.